CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth

British Journal of Cancer

Volumn 104, Issue 3, 2011, Pages 496-504

  Guilmain, W ^a,b   Colin, S ^a   Legrand, E ^b   Vannier, J P ^b   Steverlynck, C ^a   Bongaerts, M ^a   Vasse, M ^b   Al Mahmood, S ^a  

^a Gene Signal Laboratories   (France)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

CD9; CD9P 1; lung cancer; tetraspanin; tumour growth

Indexed keywords

ANTINEOPLASTIC AGENT; CD81 ANTIGEN; CD9 ANTIGEN; CD9P I ANTIGEN; CISPLATIN; GS 168AT2; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; DOWN REGULATION; DRUG MECHANISM; FEMALE; HUMAN; HUMAN TISSUE; LUNG CANCER; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79551595363     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6606033     Document Type: Article

References (38)

1. Adachi M, Taki T, Konishi T, Huang CI, Higashiyama M, Miyake M (1998) Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression. J Clin Oncol 16: 1397-1406
2. André M, Morelle W, Planchon S, Milhiet PE, Rubinstein E, Mollicone R, Chamot-Rooke J, Le Naour F (2007) Glycosylation status of the membrane protein CD9P-1. Proteomics 7: 3880-3895
3. Balsari A, Tortoreto M, Besusso D, Petrangolini G, Sfondrini L, Maggi R, Ménard S, Pratesi G (2004) Combination of a CpG oligodeoxynucleotide and a topoisomerase I inhibitor in the therapy of human tumour xenografts. Eur J Cancer 40: 1275-1281
4. Boucheix C, Duc GH, Jasmin C, Rubinstein E (2001) Tetraspanins and malignancy. Expert Rev Mol Med 31: 1-17
5. Boucheix C, Rubinstein E (2001) Tetraspanins. Cell Mol Life Sci 58: 1189-1205
6. Chambrion C, Le Naour F (2010) The tetraspanins CD9 and CD81 regulate CD9P1-induced effects on cell migration. PLoS One 5(6): e11219
7. Charrin S, Le Naour F, Oualid M, Billard M, Faure G, Hanash SM, Boucheix C, Rubinstein E (2001) The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J Biol Chem 276: 14329-14337
8. Charrin S, Le Naour F, Silvie O, Milhiet PE, Boucheix C, Rubinstein E (2009) Lateral organization of membrane proteins: tetraspanins spin their web. Biochem J 420: 133-1354
9. Charrin S, Manié S, Billard M, Ashman L, Gerlier D, Boucheix C, Rubinstein E (2003) Multiple levels of interactions within the tetraspanin web. Biochem Biophys Res Commun 304: 107-112
10. Chen MS, Tung KS, Coonrod SA, Takahashi Y, Bigler D, Chang A, Yamashita Y, Kincade PW, Herr JC, White JM (1999) Role of the integrin-associated protein CD9 in binding between sperm ADAM 2 and the egg integrin alpha6beta1: implications for murin fertilization. Proc Natl Acad Sci USA 96: 11830-11835
11. Choi YS, Noh SE, Lim SM (2008) Multipotency and growth characteristic of periosteum-derived progenitor cells for chondrogenic, osteogenic, and adipogenic differentiation. Biotechnol Lett 30: 593-601
12. Colin S, Guilmain W, Schneider C, Bongaerts M, Steverlynck C, Legrand E, Vasse M, Al-Mahmood S (2010) CD9-partner 1(CD9-P1) regulates angiogenesis and tumor growth. Mol Pharmacol (submitted for publication)
13. Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489
14. Funakoshi T, Tachibana I, Hoshida Y, Kimura H, Takeda Y, Kijima T, Nishino K, Goto H, Yoneda T, Kumagai T, Osaki T, Hayashi S, Aozasa K, Kawase I (2003) Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer. Oncogene 22: 674-687
15. Hemler ME (2003) Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol 19: 397-422
16. Hemler ME (2005) Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6: 801-811
17. Hemler ME (2008) Targeting of tetraspanin proteins - potential benefits and strategies. Nat Rev Drug Discov 7: 747-758
18. Higashiyama M, Taki T, Ieki Y, Adachi M, Huang CL, Koh T, Kodama K, Doi O, Miyake M (1995) Reduced motility related protein-1 (MRP-1/ CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res 55: 6040-6044
19. Houle CD, Ding XY, Foley JF, Afshari CA, Barrett JC, Davis BJ (2002) Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression. Gynecol Oncol 86: 69-78
20. Klein-Soyer C, Azorsa DO, Cazenave JP, Lanza F (2000) CD9 participates in endothelial cell migration during in vitro wound repair. Arterioscler Thromb Vasc Biol 20: 360-369
21. Kotha J, Longhurst C, Appling W, Jennings LK (2008) Tetraspanin CD9 regulates beta 1 integrin activation and enhances cell motility to fibronectin via a PI-3 kinase dependent pathway. Exp Cell Res 314: 1811-1822
22. Kusukawa J, Ryu F, Kameyama T, Mekada E (2001) Reduced expression of CD9 in oral squamous cell carcinoma: CD9 expression inversely related to high prevalence of lymph node metastasis. J Oral Pathol Med 30: 73-79
23. Lazo PA (2007) Functional implications of tetraspanin proteins in cancer biology. Cancer Sci 11: 1666-1677
24. Maecker HT, Todd SC, Levy S (1997) The tetraspanin superfamily: molecular facilitators. FASEB J 11: 428-442
25. Murayama Y, Miyagawa J, Shinomura Y, Kanayama S, Isozaki K, Yamamori K, Mizuno H, Ishiguro S, Kiyohara T, Miyazaki Y, Taniguchi N, Higashiyama S, Matsuzawa Y (2002) Significance of the association between heparin-binding epidermal growth factorlike growth factor and CD9 in human gastric cancer. Int J Cancer 98: 505-513
26. Ono M, Handa K, Sonnino S, Withers DA, Nagai H, Hakomori S (2001) GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. Biochemistry 40: 6414-6421
27. Orlicky DJ (1996) Negative regulatory activity of a prostaglandin F2 alpha receptor associated protein (FPRP). Prostaglandins Leukot Essent Fatty Acids 54: 247-259
28. Orlicky DJ, Lieber JG, Morin CL, Evans RM (1998) Synthesis and accumulation of a receptor regulatory protein associated with lipid droplet accumulation in 3T3-L1 cells. J Lipid Res 39: 1152-1161
29. Sauer G, Windisch J, Kurzeder C, Heilmann V, Kreienberg R, Deissler H (2003) Progression of cervical carcinomas is associated with downregulation of CD9 but strong local re-expression at sites of transendothelial invasion. Clin Cancer Res 9: 6426-6431
30. Stipp CS, Orlicky D, Hemler ME (2001) FPRP, a major, highly stoichiometric, highly specific CD81- and CD9-associated protein. J Biol Chem 276: 4853-4862
31. Takeda Y, He P, Tachibana I, Zhou B, Miyado K, Kaneko H, Suzuki M, Minami S, Iwasaki T, Goya S, Kijima T, Kumagai T, Yoshida M, Osaki T, Komori T, Mekada E, Kawase I (2008) Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice. J Biol Chem 283: 26089-26097
32. Tarrant JM, Robb L, van Spriel AB, Wright MD (2003) Tetraspanins: molecular organizers of the leukocyte surface. Trends Immunol 24: 610-617
33. Uchida S, Shimada Y, Watanabe G, Li ZG, Hong T, Miyake M, Imamura M (1999) Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 79: 1168-1173
34. Vidal-Laliena M, Romero X, March S, Requena V, Petriz J, Engel P (2005) Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistry. Cell Immunol 236: 6-16
35. Wang XY, Liu T, Zhu CZ, Li Y, Sun R, Sun CY, Wang AX (2005) Expression of KAI1, MRP-1, and FAK proteins in lung cancer detected by highdensity tissue microarray. Ai Zheng 24: 1091-1095
36. Xu M, Chen L, Christman JK (1994) Regulation of CD9 expression during 12-O-tetradecanoyl phorbol-13-acetate-induced differentiation of human myeloid leukemia (HL-60) cells. Cell Growth Differ 5: 1225-1234
37. Yunta M, Lazo PA (2003) Tetraspanin proteins as organisers of membrane microdomains and signalling complexes. Cell Signal 15: 559-564
38. Zöller M (2009) Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 9: 40-55